Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn28resultaten gevonden
Medicatieveiligheid

Health Alliance for Prudent Prescription and Yield of Antibiotics in a Patient-centred Perspective (HAPPY PATIENT) – the role of community pharmacies

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Maarten Lambert
  • Promoters K. Taxis L. van Dijk
  • Jaar 2021-2025

European funded project to reduce the inappropriate use of antibiotics in common infectious diseases by implementing EU guidelines for the prudent use of antimicrobials in human health. Implementing the Audit Project Odense (APO) methodology in community pharmacies in 5 European countries (France, Spain, Lithuania, Poland and Greece).

Medicatieveiligheid

The role of the community pharmacist in diabetes care in Indonesia

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus I. Cahyaningsih
  • Promoters K. Taxis P. Denig
  • Jaar 2021-2025

How to expand the role of the community pharmacist in Indonesia in diabetes care. 
 

Medicatieveiligheid

Application of multinational pharmacoepidemiologic studies

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus C.O. Torre
  • Promoters K. Taxis I. Wong
  • Jaar 2021-2025

The research project aims to perform a multinational pharmacoepidemiologic study in order to examine the mental health effects of the COVID-19 pandemic across vulnerable groups, including people with established psychiatric disorders including dementia and neurodevelopmental disorders.

Farmaco-economie

Optimization of the evaluation of oncology drugs for reimbursement

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Sharon Wolters
  • Promoters M. Postma F.G.A. Jansman
  • Jaar 2019-2025

The research focusses on several aspects related to reimbursement: factors influencing the time to reimbursement, measures to improve the time to reimbursement, differences in the clinical evidentiary requirements of oncology assessment, EMA versus HTA bodies and changes in economic evaluations of oncology drugs in time.
 

Farmaco-economie

Towards personalized and cost-effective care for depression

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Fang Li
  • Promoters T.L. Feenstra
  • Co-Promoters F. Jörg
  • Jaar 2021-2025

The research project aims to develop models for the prediction of disease duration in order to support personalized and cost-effective care of depression patients. Using these models, optimal treatment strategies will be analyzed. In this project, we also want to predict treatment resistant depression as a specific subgroup and conduct cost-effectiveness analyses of different psychotherapy strategies and quantify the impact of structural uncertainty and parameter uncertainty on the results of cost-effectiveness evaluations.
 

Farmaco-economie

Cost-effectiveness of personalized cardiovascular disease prevention for patients with type 2 Diabetes Mellitus: Empirical and model-based studies using real-world data

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Zhuolin Zhang
  • Promoters T.L. Feenstra E. Hak
  • Co-Promoters F. Klont
  • Jaar 2024-2028

Economische aspecten van gepersonaliseerde hart- en vaatziektepreventie bij personen met type 2 Diabetes Mellitus.
 

Medicatieveiligheid

Improving the collection and analysis of pregnancy pharmacovigilance data

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Y.R.J. van Rijt-Weetink
  • Promoters E.P. van Puijenbroek A.C.G. Egberts (RUU)
  • Co-Promoters F.P.A.M. van Hunsel
  • Jaar 2022-2026

Onderzoek naar de klinische kwaliteit van meldingen van mogelijke bijwerkingen bij blootstelling aan geneesmiddelen tijdens de zwangerschap en factoren die de aard van de gemelde bijwerkingen beïnvloeden.
 

Pagina 2 van 4